Lynk Pharmaceuticals picks up $50m Series B
Lynk Pharmaceuticals, a pharmaceutical R&D company, has secured $50 million in Series B financing.
Lynk Pharmaceuticals, a pharmaceutical R&D company, has secured $50 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination
